Axsome Therapeutics (NASDAQ:AXSM) Raised to "Strong-Buy" at Cantor Fitzgerald - MarketBeat
3 hours ago • Google News
Axsome Therapeutics Inc (AXSM)
US$ 132.24.03%
Price Chart
Key Statistics
Market Cap
$ 5.29B
P/E Ratio
0.00
Revenue (TTM)
$ 432.16M
Volume
1.63M
52W High
$ 139.13
52W Low
$ 64.11
Dividend Yield
0.00%
Beta
0.45
Technicals
50-Day MA
111.6275
200-Day MA
100.2815
52 Week High
139.1299
52 Week Low
64.11
About AXSM
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
Employees
712
Headquarters
New York, NY
CEO
Dr. Herriot Tabuteau M.D.
Latest News
Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline - Yahoo Finance
4 weeks ago • Google News
AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y - Nasdaq
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg